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Mikael Rabaeus1*, Patricia Salen2 and Michel de Lorgeril2Abstract
Metabolic syndrome is considered as mainly caused by a deleterious lifestyle (sedentarity and diet). That smoking
contributes to metabolic syndrome had been suggested by several small studies and a meta-analysis. The
interesting study by Slagter et al. published in BMC Medicine is the first very large study confirming this association
in both genders, in all classes of body mass index, and in a dose-related manner. Surprisingly, smoking is even
associated with increased abdominal fat. Rather than a direct causal effect of smoking, the reason for these
associations is most probably the frequent presence of other lifestyle components in smokers. For example, physical
inactivity and alcohol drinking are known to be more often present in smokers and could completely explain the
observations of the Slagter et al. study. Unfortunately, these factors, already not properly checked in the first studies,
were not assessed at all in the present one. However, as it is still on-going, we hope that other lifestyle factors will
be included in future publications.
Please see related research: http://www.biomedcentral.com/1741-7015/11/195.
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Both smoking and the metabolic syndrome (MetS) - defined
as a cluster of biological and physiological characteristics
[1,2] - are positively associated with an increased risk of car-
diovascular disease (CVD), cancer and all-cause mortality
[3-6].
Are these associations causal? One way to answer this
question is to determine the possible biological mecha-
nisms that would underlie causality. Such mechanisms,
by which chronic smoking results in more cancers and
CVD, are fairly established [7,8]. By contrast, the mecha-
nisms behind the association between MetS and either
cancers or CVD are much less clear [2]. We do not
know whether this association is the consequence of the
deleterious lifestyle itself having led to MetS, or of the
specific metabolic abnormalities that characterize MetS.
For example, is it the lack of physical exercise that is
harmful, or the high triglyceride and/or low high-density
lipoprotein (HDL) levels resulting from the lack of physical
exercise? Importantly, the clinical management of MetS -* Correspondence: mikael.rabaeus@bluewin.ch
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reproduction in any medium, provided the orand therefore the prevention of CVD and cancer - will
depend on this understanding of the relationship be-
tween MetS and cancer or CVD [2]. In the first hypoth-
esis, prevention would be exclusively based on lifestyle
changes. In the second case, physicians would have to
concentrate on prescribing drugs - whatever the toxic
side-effects [2] - to minimize the various parameters
that characterize MetS [2].Discussion
One important lifestyle issue is whether smoking by it-
self may increase the prevalence of MetS. Several studies
have shown an association between smoking and some
characteristics of MetS: high triglycerides, low HDL,
high body mass index (BMI) or abdominal obesity
[9-11]. Moreover, in some of these studies, the number
of cigarettes smoked per day was linearly associated with
the degree of abdominal obesity among smokers; how-
ever, no significant difference was observed between
smokers and nonsmokers [12]. It must not be forgotten
that smoking cessation is known to result in significant
weight gain [13], which in turn may, in theory, reducel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cessation.
In the context of these quite confusing data, the study
by Slagter and colleagues is welcome [14]. Analyzing
data from a very large population-based cohort study
(about 60,000 people), they report that smoking is asso-
ciated with a higher risk of MetS in both genders and in
all BMI classes. This important finding confirms a previ-
ous meta-analysis summarizing data from 13 studies,
involving 56,000 participants, in which Sun et al. also
detected a significant positive association between smok-
ing and risk of MetS [11]. The increased risk was strong
for heavy smokers but not significant among light and
former smokers, which suggested a kind a dose-effect re-
lationship between smoking and MetS, possibly indicat-
ing a causal relationship. There are, however, many
limitations in such a meta-analysis with, for instance,
various definitions of MetS across studies, racial differ-
ences in the study populations and substantial hetero-
geneity in the way of measuring exposure and cofactors.
Thus, analyzing a single large and homogeneous popula-
tion as done by Slagter and colleagues is very important
[14]. All the more so because such a comprehensive and
large-scale analysis has not been performed to date.
Slagter et al. also investigated the relationship between
smoking and the individual components of MetS. The
largest differences between smokers and nonsmokers
were observed in the levels of HDL and triglycerides,
and - to a lesser extent - in waist circumference. This
was observed in both men and women, irrespective of
their BMI. By contrast, there was no association between
smoking and either blood pressure or fasting blood
glucose.
Such a kind of dose–response relationship between
smoking and MetS components, with the largest effect
on HDL and triglycerides, had already been observed in
another study, comprising 1,164 men, in those who
smoked more than 40 cigarettes per day [9].
One surprising observation in these studies - going
against current knowledge - is the positive relationship
between smoking and abdominal obesity. It is generally
admitted that quitting smoking usually results in weight
gain. Smoking is therefore expected to be inversely cor-
related with weight and BMI. So how can we explain
that smoking may increase some forms of obesity? This
leads to a fundamental question: is it smoking itself that
results in higher risk of MetS or some lifestyle factors
associated with smoking?
The overall lifestyle of smokers is generally considered
different from the lifestyle of nonsmokers. Accordingly,
multiple interactions with other lifestyle factors are
expected in smokers. It is likely that the main confusing
interaction in the association of smoking with obesity
and MetS parameters lies in physical activity. Sure enough,jogging and cycling are rarely the preferred leisure activ-
ities of smokers. And indeed, in most people, a lack of
exercise results in overweight, high triglycerides and
low HDL. Furthermore, as shown by Ortega et al. [15],
the main factor characterizing so-called metabolically
healthy obese individuals (that is, not fulfilling the cri-
teria for MetS) is higher fitness. Even when fitness is
taken into account, metabolically healthy obese individ-
uals have a better prognosis than non-obese unhealthy
ones. Importantly, fitness was estimated through an ex-
ercise test. Estimating physical activity through a ques-
tionnaire is very often flawed, as the participants are
prone to overestimate their level of physical activity. As
an example, in a study by Chen et al. [9], physical activity
was higher (!) among smokers than in former or non-
smokers. This is all the more surprising because smokers
had a lower socioeconomic level, a known risk factor for a
sedentary lifestyle.
Smoking is also known to be associated with specific
alcohol drinking and eating habits. In some (not all)
populations, heavy smokers are also heavy drinkers, a
habit that may result in weight gain, high triglycerides
and high blood pressure, and high HDL. Here again,
the relationship between drinking itself and some MetS
parameters are complex as other lifestyle factors -
including physical activity again - potentially interact with
both smoking and drinking. The relationship between
drinking and metabolic parameters usually show U- or
J-curve aspects: light and moderate drinkers do have
better profiles than nondrinkers whereas heavy drinkers
present worse profiles compared with light and moder-
ate drinkers and even nondrinkers. But then, light or
moderate drinking is usually associated with healthier
lifestyle. Therefore, heavy, moderate and light drinking
are not just a question of quantity but also of global life-
style. It becomes important to differentiate between
them when including drinking as a cofactor in the ana-
lyses of the association between smoking and MetS. The
types of beverages - wine versus others - as well as the
way of drinking (binge versus others) are additional con-
founding factors. So heavy, moderate or light smokers
and drinkers do not only have different physical activity
habits, but also different dietary habits, both playing a
clear role in determining MetS characteristics [16-18].
Finally, socioeconomic variables also interfere with life-
style [19].
Unfortunately, in most studies analyzing the relation-
ships between smoking and MetS, including the one by
Slagter and colleagues [14], these multiple and critical
lifestyle factors are not measured and analyzed. This is
a major limitation - as underlined by most authors -
and precludes drawing definite conclusions regarding
the effect of smoking on MetS. However, as the study
by Slagter et al. is still ongoing, we hope the investigators
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future.
Conclusion
Despite some limitations, the study by Slagter et al.
provides more evidence that long-term lifestyle changes -
including smoking cessation - must be the first-line approach
to reduce the prevalence of MetS and of its complications.
Indeed, it was recently shown that smoking cessation is
associated with a lower risk of CVD complications what-
ever the effects on metabolic parameters, including weight
gain [20]. So, in conclusion, when helping smokers to quit,
it is critical to educate them on other aspects of a healthy
lifestyle.
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